Correlation Between Alger Health and Evaluator Aggressive

Can any of the company-specific risk be diversified away by investing in both Alger Health and Evaluator Aggressive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alger Health and Evaluator Aggressive into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alger Health Sciences and Evaluator Aggressive Rms, you can compare the effects of market volatilities on Alger Health and Evaluator Aggressive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alger Health with a short position of Evaluator Aggressive. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alger Health and Evaluator Aggressive.

Diversification Opportunities for Alger Health and Evaluator Aggressive

0.23

Correlation Coefficient

Alger Health  Evaluator Aggressive

Modest diversification

The 3 months correlation between Alger and Evaluator is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Alger Health Sciences and Evaluator Aggressive Rms in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaluator Aggressive Rms and Alger Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alger Health Sciences are associated (or correlated) with Evaluator Aggressive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaluator Aggressive Rms has no effect on the direction of Alger Health i.e., Alger Health and Evaluator Aggressive go up and down completely randomly.

Pair Corralation between Alger Health and Evaluator Aggressive

Assuming the 90 days horizon Alger Health is expected to generate 2.05 times less return on investment than Evaluator Aggressive. In addition to that, Alger Health is 1.2 times more volatile than Evaluator Aggressive Rms. It trades about 0.07 of its total potential returns per unit of risk. Evaluator Aggressive Rms is currently generating about 0.18 per unit of volatility. If you would invest  1,389  in Evaluator Aggressive Rms on May 20, 2025 and sell it today you would earn a total of  101.00  from holding Evaluator Aggressive Rms or generate 7.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Alger Health Sciences  vs.  Evaluator Aggressive Rms

Alger Health Sciences

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Alger Health Sciences are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong fundamental indicators, Alger Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Evaluator Aggressive Rms

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Evaluator Aggressive Rms are ranked lower than 14 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak technical and fundamental indicators, Evaluator Aggressive may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pair Trading with Alger Health and Evaluator Aggressive

The main advantage of trading using opposite Alger Health and Evaluator Aggressive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alger Health position performs unexpectedly, Evaluator Aggressive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaluator Aggressive will offset losses from the drop in Evaluator Aggressive's long position.

The idea behind Alger Health Sciences and Evaluator Aggressive Rms pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.